TITLE

Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging

AUTHOR(S)
Satake, H.; Shimamoto, K.; Sawaki, A.; Niimi, R.; Ando, Y.; Ishiguchi, T.; Ishigaki, T.; Yamakawa, K.; Nagasaka, T.; Funahashi, H.
PUB. DATE
November 2000
SOURCE
European Radiology;Nov2000, Vol. 10 Issue 11, p1726
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
The purpose of this study was to assess the role of US in the detection of intraductal spread of breast cancer in comparison with mammography (MMG) and MRI. In 46 patients with breast cancer, US features of the intraductal component were classified as ductal type or distorted type. Histopathologically, 29 of 46 (63%) cases had intraductal components, and the sensitivity, specificity, and accuracy rates in detection of intraductal spread were 89, 76, and 85%, respectively. Each US pattern demonstrated good correspondence to the histologic components, and the distorted type correlated well with comedo-type carcinoma. Mammography was performed in all cases, and the sensitivity, specificity, and accuracy rates in detection of intraductal spread were 55, 100, and 72%, respectively. In comedo type, MMG could diagnose the extent of intraductal spread more accurately compared with US examination. Magnetic resonance imaging comparison was available in 25 cases. Magnetic resonance imaging depicted intraductal extension as an enhanced area during the early phase of a contrast enhancement study with a sensitivity of 93%. Ultrasound and MRI were closely related in terms of morphologic characteristics: the ductal type of US image correlated well with linear enhancement on MRI, whereas the distorted type correlated with regional or segmental enhancement. Current US examination is useful in depicting the intraductal spread of breast cancer; however, US has a tendency to underestimate intraductal component of comedo type compared with MMG and MRI.
ACCESSION #
15654254

 

Related Articles

  • Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkins lymphoma. L. Lee; M. Pintilie; D. C. Hodgson; P. E. Goss; M. Crump // Annals of Oncology;Jan2008, Vol. 19 Issue 1, p62 

    Background: Female survivors of Hodgkins lymphoma (HL) treated with supradiaphragmatic radiation therapy (SRT) are at increased risk of breast cancer (BC), but there is little data on the optimal screening strategy. Patient and methods: We report a prospective surveillance study of women treated...

  • MRIs more accurate than mammograms but expensive. Eggertson, Laura // CMAJ: Canadian Medical Association Journal;10/12/2004, Vol. 171 Issue 8, p840 

    Focuses on two studies which investigated the accuracy of magnetic resonance imaging (MRI) in detecting early breast cancer. Procedures of the studies; Costs of an MRI scan compared to a mammogram; Disadvantages of mammography.

  • Researchers Seek Mammography Alternatives. Mitka, Mike // JAMA: Journal of the American Medical Association;7/23/2003, Vol. 290 Issue 4, p450 

    Discusses film-screen mammography, a breast-cancer detection tool, and its drawbacks. Statistics from studies showing the limitations of mammography when screening young women or those with dense breasts; Limitations of the alternative technologies, ultrasound and magnetic resonance imaging...

  • Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination. Warner, Ellen; Plewes, Donald B.; Hill, Kimberley A.; Causer, Petrina A.; Zubovits, Judit T.; Jong, Roberta A.; Cutrara, Margaret R.; DeBoer, Gerrit; Yaffe, Martin J.; Messner, Sandra J.; Meschino, Wendy S.; Piron, Cameron A.; Narod, Steven A. // JAMA: Journal of the American Medical Association;9/15/2004, Vol. 292 Issue 11, p1317 

    Context Current recommendations for women who have a BRCA1 or BRCA2 mutation are to undergo breast surveillance from age 25 years onward with mammography annually and clinical breast examination (CBE) every 6 months; however, many tumors are detected at a relatively advanced stage. Magnetic...

  • Breast Cancers Detected by Breast MRI Screening and Ultrasound in Asymptomatic Asian Women: 8 Years of Experience in Taiwan. Cheng, Yu-Chen; Wu, Nai-Yuan; Ko, James S.; Lin, Po-Wei; Lin, Wei-Chan; Juang, Shiow-Jen; Tsai, Tsung-Tsung; Chang, Cheng-Yen; Chen, Jeon-Hor; Cheng, Hui-Cheng // Oncology;Mar2012, Vol. 82 Issue 2, p98 

    Background: This study investigated one-stop breast screening combining magnetic resonance imaging (MRI) and ultrasound (US) in asymptomatic Asian women. Methods: 3,586 asymptomatic women (mean age, 45.3 years) were retrospectively analyzed by breast MRI followed by US. US-guided biopsy was...

  • Bonn Study Was Interpreted Incorrectly. Schild, Hans H. // Deutsches Aerzteblatt International;2/27/2009, Vol. 106 Issue 9, p1 

    The article presents the author's views on the summarization of the results of the study on the diagnosis of pure ductal carcinoma in situ (DCIS) that was conducted by C. K. Kuhl and colleagues. He says that the summarization is misleading and it reports that the study has found that high grade...

  • Accepting the Existence of Breast Cancer Overdiagnosis. Brawley, Otis W. // Annals of Internal Medicine;3/7/2017, Vol. 166 Issue 5, p364 

    The author focuses on the existence and death rate due to breast cancer in Denmark. It presents information on over diagnosis and cancer screening of breast cancer in the population. It also presents information on the evolution of imaging diagnostics including mammography, ultrasonography,...

  • Ultrashort Echo Time for Improved Positive-Contrast Manganese-Enhanced MRI of Cancer. Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Objective: Manganese (Mn) is a positive magnetic resonance imaging (MRI) contrast agent that has been used to obtain physiological, biochemical, and molecular biological information. There is great interest to broaden its applications, but a major challenge is to increase detection sensitivity....

  • Agreement of Mammographic Measures of Volumetric Breast Density to MRI. Wang, Jeff; Azziz, Ania; Fan, Bo; Malkov, Serghei; Klifa, Catherine; Newitt, David; Yitta, Silaja; Hylton, Nola; Kerlikowske, Karla; Shepherd, John A. // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Background: Clinical scores of mammographic breast density are highly subjective. Automated technologies for mammography exist to quantify breast density objectively, but the technique that most accurately measures the quantity of breast fibroglandular tissue is not known. Purpose: To compare...

  • Cancer screening gets down to the bone.  // New Scientist;8/28/93, Vol. 139 Issue 1888, p16 

    Reports on claims that spread of cancer to the bone can be detected through magnetic resonance imaging (MRI). Mark Swetizer of Thomas Jefferson University Hospital in Philadelphia and Charles Levine of the University of Medicine and Dentistry in New Jersey; `Bull's-eye' and `halo' signs;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics